Abstract
A 64-year-old man with a history of gallstones, common bile duct stones, chronic hepatitis B virus infection, and hepatic cirrhosis with a Child-Pugh score B was satisfactorily treated for hepatocellular carcinoma with radiofrequency ablation and transarterial chemoembolization. His course, however, was complicated by gallbladder actinomycosis 14 months after treatment, resulting in acute cholecystitis. Such a chain of events suggests that gallbladder actinomycosis may develop after radiofrequency ablation and transarterial chemoembolization in patients who are known to have gallstones and that asymptomatic gallstones should be treated before the application of nonsurgical, but invasive procedures for hepatocellular carcinoma.
[1] Russo T. Agents of actinomycosis. In Mandell G, Bennett J, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. New York: Churchill-Livingstone, 2000. pp. 2645–2654 Search in Google Scholar
[2] Charalabopoulos K, Charalabopoulos AK, Papalimneou V, et al. Lung, pleural and colon actinomycosis in an immunocompromised patient: a rare form of presentation. Chemotherapy. 2003;49:209–211 http://dx.doi.org/10.1159/00007114710.1159/000071147Search in Google Scholar
[3] Dominguez DC, Antony SJ. Actinomyces and nocardia infections in immunocompromised and nonimmunocompromised patients. J Natl Med Assoc. 1999;91:35–39 Search in Google Scholar
[4] Fry RD, Birnbaum EH, Lacey DL. Actinomyces as a cause of recurrent perianal fistula in the immunocompromised patient. Surgery. 1992;111:591–594 Search in Google Scholar
[5] Richman M, Jeng A. Intra-abdominal co-infection with Mycobacterium bovis and Actinomyces in an AIDS patient: the first reported case and review. J Infect. 2007;55:e115–118 http://dx.doi.org/10.1016/j.jinf.2007.07.00610.1016/j.jinf.2007.07.006Search in Google Scholar
[6] Leach TD, Sadek SA, Mason JC. An unusual abdominal mass in a renal transplant recipient. Transpl Infect Dis. 2002;4:218–222 http://dx.doi.org/10.1034/j.1399-3062.2002.t01-1-01009.x10.1034/j.1399-3062.2002.t01-1-01009.xSearch in Google Scholar
[7] Freland C, Massoubre B, Horeau JM, et al. Actinomycosis of the gallbladder due to Actinomyces naeslundii. J Infect. 1987;15:251–257 http://dx.doi.org/10.1016/S0163-4453(87)92753-810.1016/S0163-4453(87)92753-8Search in Google Scholar
[8] Ormsby AH, Bauer TW, Hall GS. Actinomycosis of the cholecystic duct: case report and review. Pathology. 1998;30:65–67 http://dx.doi.org/10.1080/0031302980016969510.1080/00313029800169695Search in Google Scholar
[9] Wagenlehner FM, Mohren B, Naber KG, et al. Abdominal actinomycosis. Clin Microbiol Infect. 2003;9:881–885 http://dx.doi.org/10.1046/j.1469-0691.2003.00653.x10.1046/j.1469-0691.2003.00653.xSearch in Google Scholar
[10] Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol. 2007;85:16–23 http://dx.doi.org/10.1038/sj.icb.710000910.1038/sj.icb.7100009Search in Google Scholar
[11] Santos LD, Rogan KA, Kennerson AR. Cytologic diagnosis of suppurative cholecystitis due to Candida albicans and actinomyces. A report of 2 cases. Acta Cytol. 2004;48:407–410 http://dx.doi.org/10.1159/00032639410.1159/000326394Search in Google Scholar
[12] Hamid D, Baldauf JJ, Cuenin C, et al. Treatment strategy for pelvic actinomycosis: case report and review of the literature. Eur J Obstet Gynecol Reprod Biol. 2000;89:197–200 http://dx.doi.org/10.1016/S0301-2115(99)00173-610.1016/S0301-2115(99)00173-6Search in Google Scholar
[13] Bennhoff DF. Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases. Laryngoscope. 1984;94:1198–1217 http://dx.doi.org/10.1288/00005537-198409000-0001310.1288/00005537-198409000-00013Search in Google Scholar PubMed
© 2011 Versita Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
